Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Inovio’s HIV vaccine succeeds in early stage trial Inovio Pharmaceuticals' Pennvax-GP HIV vaccine has demonstrated nearly 100% immune response rates in a clinical study. Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Neurocrine’s Ingrezza fails in phase II Tourette syndrome study
Neurocrine Biosciences said that the initial phase II Tourette syndrome T-Force GREEN study of INGREZZA (valbenazine), a small molecule VMAT2 inhibitor, did not meet its primary endpoint.
Contract Research & Services > Clinical Trials > News
Inovio’s HIV vaccine succeeds in early stage trial
Inovio Pharmaceuticals' Pennvax-GP HIV vaccine has demonstrated nearly 100% immune response rates in a clinical study.
Contract Research & Services > Clinical Trials > News

Contract Research

Thermo Fisher to buy pharmaceutical CDMO Patheon for $7.2bn
By PBR Staff Writer
Thermo Fisher Scientific has agreed to acquire Patheon, a provider of drug development and delivery solutions to the pharmaceutical and biopharma sectors, for around $7.2bn.
Contract Research & Services > Contract Research > News
Poxel’s diabetes drug Imeglimin succeeds in phase 2b study in Japan
Poxel has announced positive top line results of a Phase 2b trial of Imeglimin for type 2 diabetes treatment in Japan.
Contract Research & Services > Contract Research > News

Contract Services

Debiopharm acquires ImmunoGen’s ADC IMGN529/Debio 1562
Debiopharm International has acquired ImmunoGen's IMGN529/Debio 1562, a clinical-stage anti-CD37 ADC for the treatment of patients with B-cell malignancies, such as non-Hodgkin lymphomas (NHL).
Contract Research & Services > Contract Services > News
INC Research, inVentiv agree to merge in $4.6bn deal
By PBR Staff Writer
INC Research has agreed to acquire US-based contract research organization (CRO) inVentiv Health in all stock deal worth nearly $4.6bn.
Contract Research & Services > Contract Services > News